Follow this preprint

Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off

Heather J Whitaker, Charlotte Gower, Ashley D Otter, Ruth Simmons, Freja Kirsebom, Louise Letley, Catherine Quinot, Georgina Ireland, Ezra Linley, Sonia Ribeiro, Shamez Ladhani, Jamie Lopez-Bernal, Gayatri Amirthalingam, Mary E Ramsay, Kevin E Brown
doi: https://doi.org/10.1101/2021.10.25.21264964
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2021.10.25.21264964
History 
  • October 26, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Heather J Whitaker1,*,
  2. Charlotte Gower2,
  3. Ashley D Otter3,
  4. Ruth Simmons2,
  5. Freja Kirsebom2,
  6. Louise Letley2,
  7. Catherine Quinot2,
  8. Georgina Ireland2,
  9. Ezra Linley4,
  10. Sonia Ribeiro2,
  11. Shamez Ladhani2,5,
  12. Jamie Lopez-Bernal2,
  13. Gayatri Amirthalingam2,
  14. Mary E Ramsay2 and
  15. Kevin E Brown2
  1. 1Statistics, Modelling and Economics Department, National Infection Service, Public Health England, Colindale, London, UK
  2. 2Immunisations and Countermeasures Division, National Infection Service, Public Health England, Colindale, London, UK
  3. 3Diagnostics and Genomics, National Infection Service, Public Health England, Porton Down, UK
  4. 4Vaccine Evaluation Unit, National Infection Service, Public Health England, Manchester, UK
  5. 5Paediatric Infectious Diseases Research Group, St. George’s University of London, Cranmer Terrace, London SW17 0RE, UK
  1. ↵*Corresponding author, e-mail: heather.whitaker{at}phe.gov.uk
Back to top
Posted October 26, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off
Heather J Whitaker, Charlotte Gower, Ashley D Otter, Ruth Simmons, Freja Kirsebom, Louise Letley, Catherine Quinot, Georgina Ireland, Ezra Linley, Sonia Ribeiro, Shamez Ladhani, Jamie Lopez-Bernal, Gayatri Amirthalingam, Mary E Ramsay, Kevin E Brown
medRxiv 2021.10.25.21264964; doi: https://doi.org/10.1101/2021.10.25.21264964
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

2

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.